Extrahepatic soft tissue mimicking applicator-tract implantation after percutaneous radiofrequency ablation of hepatic malignancy

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

OBJECTIVE. The purpose of our study was to identify extrahepatic soft tissue mimicking applicator-tract implantation after percutaneous radiofrequency ablation of hepatic malignancy on triple-phase dynamic CT. MATERIALS AND METHODS. A database was reviewed for 131 patients who underwent percutaneous radiofrequency ablation for treatment of a hepatic tumor over a 3-year period. Patients who developed extrahepatic soft tissue adjacent to the previous ablation zone mimicking applicator-tract implantation were identified. The clinical features of patients, characteristics of extrahepatic soft tissue on CT, soft-tissue changes on follow-up CT, and histopathologic results were evaluated. RESULTS. Extrahepatic soft tissue developed in five patients (3.8%) at 2-8 months after percutaneous radiofrequency ablation. Extrahepatic soft tissue showed progressive enhancement during the delayed phase of dynamic CT. Four lesions were completely resolved without any treatment. However, one lesion was enlarged and xanthogranulomatous inflammation was diagnosed by percutaneous biopsy. Univariate analysis showed that an index tumor with a subcapsular location and a prior biopsy had high odds ratios. CONCLUSION. The possibility of a benign inflammatory lesion should be considered when extrahepatic soft tissue showing radiologic findings similar to applicator-tract implantation develops after radiofrequency ablation of a hepatic tumor.

Original languageEnglish
Pages (from-to)453-457
Number of pages5
JournalAmerican Journal of Roentgenology
Volume199
Issue number2
DOIs
StatePublished - Aug 2012

Keywords

  • Ablation
  • CT
  • Liver
  • Neoplasm
  • Radiofrequency

Fingerprint

Dive into the research topics of 'Extrahepatic soft tissue mimicking applicator-tract implantation after percutaneous radiofrequency ablation of hepatic malignancy'. Together they form a unique fingerprint.

Cite this